Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner

Endocrinology

Volumn 148, Issue 4, 2007, Pages 1524-1538

  Dermitzaki, E ^a   Tsatsanis, C ^a   Minas, V ^a   Chatzaki, E ^b   Charalampopoulos, I ^a   Venihaki, M ^a   Androulidaki, A ^a   Lambropoulou, M ^b   Spiess, J ^c   Michalodimitrakis, E ^a   Gravanis, A ^a   Margioris, Andrew N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; TYROSINE 3 MONOOXYGENASE; UROCORTIN;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ADRENAL GLAND; ADRENAL MEDULLA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CHROMAFFIN CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENAL GLANDS; ANIMALS; CATECHOLAMINES; CELLS, CULTURED; CHROMAFFIN CELLS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE;

EID: 33947367416     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0967     Document Type: Article

References (32)

1. Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K 1984 Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 59:861-866
2. Hashimoto K, Murakami K, Hattori T, Niimi M, Fujino K, Ota Z 1984 Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla. Peptides 5:707-711
3. Dave JR, Eiden LE, Eskay RL 1985 Corticotropin-releasing factor binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3′,5′-monophosphate system. Endocrinology 116:2152-2159
4. Udelsman R, Harwood JP, Millan MA, Chrousos GP, Goldstein DS, Zimlichman R, Catt KJ, Aguilera G 1986 Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system. Nature 319:147-150
5. Aguilera G, Millan MA, Hauger RL, Catt KJ 1987 Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues. Ann NY Acad Sci 512:48-66
6. Bruhn TO, Engeland WC, Anthony EL, Gann DS, Jackson IM 1987 Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology 120:25-33
7. Willenberg HS, Bornstein SR, Hiroi N, Path G, Goretzki PE, Scherbaum WA, Chrousos GP 2000 Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function. Mol Psychiatry 5:137-141
8. Chatzaki E, Margioris AN, Gravanis A 2002 Expression and regulation of corticotropin-releasing hormone binding protein (CRH-BP) in rat adrenals. J Neurochem 80:81-90
9. Takahashi K, Totsune K, Saruta M, Fukuda T, Suzuki T, Hirose T, Imai Y, Sasano H, Murakami O 2005 Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors. Peptides 27:178-182
10. Mazzocchi G, Malendowicz LK, Rebuffat P, Gottardo G, Nussdorfer GG 1997 Neurotensin stimulates CRH and ACTH release by rat adrenal medulla in vitro. Neuropeptides 31:8-11
11. Oki Y, Iwabuchi M, Masuzawa M, Watanabe F, Ozawa M, Iino K, Tominaga T, Yoshimi T 1998 Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus. Life Sci 62:807-812
12. Yamauchi N, Otagiri A, Nemoto T, Sekino A, Oono H, Kato I, Yanaihara C, Shibasaki T 2005 Distribution of urocortin 2 in various tissues of the rat. J Neuroendocrinol 17:656-663
13. Fukuda T, Takahashi K, Suzuki T, Saruta M, Watanabe M, Nakata T, Sasano H2005 Urocortin 1, urocortin 3/stresscopin, and corticotropin- releasing factor receptors in human adrenal and its disorders. J Clin Endocrinol Metab 90:4671-4678
14. Venihaki M, Gravanis A, Margioris AN 1997 Comparative study between normal rat chromaffin and PC12 rat pheochromocytoma cells: production and effects of corticotropin-releasing hormone. Endocrinology 138:698-704
15. Venihaki M, Ain K, Dermitzaki E, Gravanis A, Margioris AN 1998 KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone. Endocrinology 139:713-722
16. Margioris AN, Venihaki M, Gravanis A 2001 Interleukin (IL)-1 family of cytokines and corticotropin-releasing hormone (CRH) in the adrenal gland. Adrenal disorders. Totowa, NJ: Humana Press
17. Nanmoku T, Takekoshi K, Fukuda T, Isobe K, Shibuya S, Kawakami Y 2005 Urocortin stimulates tyrosine hydroxylase activity via the cAMP/protein kinase a pathway in rat pheochromocytoma PC12 cells. Neurosci Lett 382:124-127
18. Kubovcakova L, Sabban EL, Kvetnansky R, Krizanova O 2002 Comparative study of catecholamine synthesizing enzymes in adrenal medulla of CRH knock-out mice, their CRH (+/+) mates and Sprague-Dawley rats. Endocr Regul 36:107-113
19. Kubovcakova L, Tybitanclova K, Sabban EL, Majzoub J, Zorad S, Vietor I, Wagner EF, Krizanova O, Kvetnansky R 2004 Catecholamine synthesizing enzymes and their modulation by immobilization stress in knockout mice. Ann NY Acad Sci 1018:458-465
20. Yoshida-Hiroi M, Bradbury MJ, Eisenhofer G, Hiroi N, Vale WW, Novotny GE, Hartwig HG, Scherbaum WA, Bornstein SR 2002 Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice. Mol Psychiatry 7:967-974
21. Dermitzaki E, Gravanis A, Venihaki M, Stournaras C, Margioris AN 2001 Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Endocrinology 142:2022-2031
22. Chatzaki E, Crowe PD, Wang L, Million M, Tache Y, Grigoriadis DE 2004 CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J Neurochem 90:309-316
23. Chatzaki E, Murphy BJ, Wang L, Million M, Ohning GV, Crowe PD, Petroski R, Tache Y, Grigoriadis DE 2004 Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodies. J Neurochem 88:1-11
24. Charalampopoulos I, Dermitzaki E, Vardouli L, Tsatsanis C, Stournaras C, Margioris AN, Gravanis A 2005 Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146:3309-3318
25. 4. Nature 227:680-685
26. Dermitzaki E, Tsatsanis C, Charalampopoulos I, Androulidaki A, Alexaki VI, Castanas E, Gravanis A, Margioris AN 2005 Corticotropin-releasing hormone activates protein kinase C in an isoenzyme-specific manner. Biochem Biophys Res Commun 327:828-836
27. Roth D, Burgoyne RD 1995 Stimulation of catecholamine secretion from adrenal chromaffin cells by 14-3-3 proteins is due to reorganisation of the cortical actin network. FEBS Lett 374:77-81
28. Zhang L, Rodriguez Del Castillo A, Trifaro JM 1995 Histamine-evoked chromaffin cell scinderin redistribution, F-actin disassembly, and secretion: in the absence of cortical F-actin disassembly, an increase in intracellular Ca2+ fails to trigger exocytosis. J Neurochem 65:1297-1308
29. Tezval H, Jahn O, Todorovic C, Sasse A, Eckart K, Spiess J 2004 Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci USA 101:9468-9473
30. Jahn O, Tezval H, van Werven L, Eckart K, Spiess J 2004 Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity. Neuropharmacology 47:233-242
31. Nakamura T, Tomomura A, Noda C, Shimoji M, Ichihara A 1983 Acquisition of a β-adrenergic response by adult rat hepatocytes during primary culture. J Biol Chem 258:9283-9289
32. Hansson E 1985 Primary cultures from defined brain areas; effects of seeding time on the development of β-adrenergic- and dopamine-stimulated cAMP-activity during cultivation. Brain Res 353:187-192